Societal CDMO, Inc.
SCTL

$116.13 M
Marketcap
$1.10
Share price
Country
$0.01
Change (1 day)
$1.28
Year High
$0.26
Year Low

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

marketcap

Revenue of Societal CDMO, Inc. (SCTL)

Revenue in 2023 (TTM): $94.64 M

According to Societal CDMO, Inc.'s latest financial reports the company's current revenue (TTM) is $94.64 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Societal CDMO, Inc.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $94.64 M $18.5 M $7.15 M $-13,142,000 $-13,274,000
2022 $90.21 M $23.14 M $8.6 M $-18,776,000 $-19,881,000
2021 $75.36 M $19.82 M $1.45 M $-11,370,000 $-26,504,000
2020 $66.5 M $12.37 M $-5,759,000 $-27,501,000 $-46,660,000
2019 $99.22 M $48.24 M $34.95 M $4.63 M $-38,436,000
2018 $77.35 M $34.19 M $-42,165,000 $-62,287,000 $-79,723,000
2017 $71.83 M $33.64 M $-24,495,000 $-51,960,000 $-50,080,000
2016 $69.34 M $32.19 M $-8,793,000 $-31,312,000 $-30,205,000
2015 $51.95 M $23.9 M $2.73 M $-12,518,000 $3.03 M
2014 $ $-7,874,000 $-11,861,239 $-16,134,158 $-16,134,158
2013 $ $ $-1,088,262 $-1,957,818 $-1,957,818
2012 $ $ $-794,233 $-1,536,536 $-1,536,536
2011 $ $ $-2,311,318 $-2,870,918 $-2,870,918